The physicians at Rigshospitalet, Copenhagen, have concluded at the final routine control scan on Friday 23 March that A.P. Moller - Maersk Group CEO Nils S. Andersen should undergo corrective surgery in connection with the prosthetic cardiac valve he got late December last year.
Nils S. Andersen has regularly attended control examinations – all with a satisfactory outcome – and it was planned ahead of the examination Friday that Nils S. Andersen would resume his duties today Monday.
The surgery is scheduled for Wednesday 28 March. As a result, Nils S. Andersen’s sick leave is extended by six to eight weeks as advised by his physicians.
“We expected and it was planned that Nils S. Andersen would resume his duties today, actually a little sooner than previously announced due to a fast and good recovery. Therefore we were naturally surprised when his physicians on Friday concluded differently. It is of course sad and regrettable that Nils S. Andersen has to undergo another operation even if planned,” says Chairman of the Board of the A.P. Moller - Maersk Group Michael Pram Rasmussen and adds:
”That said, we can with satisfaction conclude that the Group in the past three months has been well run without any loss of momentum. The separate business units are individual businesses with strong management teams. And the long term goals have been defined.”
Until now, and going forward, the Executive Board will run the A.P. Moller - Maersk Group. During Nils S. Andersen’s absence, the individual members of the Executive board will refer to the Chairman of the Board Michael Pram Rasmussen.
”We have a real strength in having a top executive management team, which works closely together and has in-depth knowledge of each other’s business areas, and at the same time has the needed authorisation to take swift decisions. The management team has passed the test and shown it is robust, and will also be able to handle the extension of Nils S. Andersen’s sick leave without any loss of momentum,” says Michael Pram Rasmussen.